Managing Antifungals in Haematology/Oncology Patients – New Guidelines

New Australian and New Zealand Consensus Guidelines for the Use of Antifungal Agents in Haematology/Oncology patients are now available.

These updated guidelines provide recommendations for antifungal drug use in paediatric patients, include an article on the management of Pneumocystis jirovecii infections and include a substantial focus on Cryptococcus gattii infection, as well as updated discussion of diagnostic testing and management strategies. The guidelines were subject to wide end-user review prior to publication and have been endorsed by ASID, ALLG and ANZCHOG.

The special issue of the Internal Medicine Journal is available here:

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: